BECHERINI, CARLOTTA
 Distribuzione geografica
Continente #
NA - Nord America 1.572
EU - Europa 697
AS - Asia 363
AF - Africa 1
Totale 2.633
Nazione #
US - Stati Uniti d'America 1.566
IT - Italia 286
IE - Irlanda 176
HK - Hong Kong 144
SE - Svezia 119
CN - Cina 104
JO - Giordania 46
SG - Singapore 38
PL - Polonia 24
DE - Germania 22
GB - Regno Unito 19
RU - Federazione Russa 17
IN - India 14
KR - Corea 10
CH - Svizzera 7
FR - Francia 6
UA - Ucraina 6
CA - Canada 5
FI - Finlandia 5
BE - Belgio 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
JP - Giappone 2
LT - Lituania 2
NL - Olanda 2
VN - Vietnam 2
DK - Danimarca 1
GL - Groenlandia 1
GR - Grecia 1
NG - Nigeria 1
PH - Filippine 1
Totale 2.633
Città #
Fairfield 207
Chandler 185
Dublin 176
Ashburn 148
Seattle 123
Woodbridge 117
Hong Kong 102
Cambridge 91
Wilmington 82
Houston 76
Altamura 46
Dearborn 45
Lawrence 43
Ann Arbor 37
Beijing 35
Princeton 31
Shanghai 28
Kent 25
Buffalo 24
Warsaw 24
Boston 23
New York 22
Florence 19
San Diego 19
Moscow 17
Singapore 14
Medford 10
Rome 10
Seoul 10
Pune 9
Boardman 8
Milan 8
West Jordan 8
London 7
Naples 7
Hillsboro 5
Somma Vesuviana 5
Fiesole 4
Guangzhou 4
Maddaloni 4
Padova 4
Qingdao 4
Wuhan 4
Zurich 4
Acerra 3
Alice Castello 3
Andover 3
Andria 3
Bern 3
Eboli 3
Falls Church 3
Fontebuona 3
Frankfurt am Main 3
Grezzana 3
Hefei 3
Munich 3
Nanjing 3
Norwalk 3
Pontedera 3
Prato 3
Qualiano 3
Redmond 3
San Felice A Cancello 3
St Louis 3
Toronto 3
Zhengzhou 3
Avellino 2
Aversa 2
Bologna 2
Brno 2
Brussels 2
Bussolengo 2
Calgary 2
Campi Bisenzio 2
Castellammare di Stabia 2
Dallas 2
Dong Ket 2
Empoli 2
Falkenstein 2
Fisciano 2
Kilburn 2
Los Angeles 2
Lucera 2
Modena 2
Nagold 2
Nutley 2
Nürnberg 2
Pagani 2
Pelago 2
Perugia 2
Redwood City 2
Romainville 2
San Genesio Ed Uniti 2
Scarperia e San Piero 2
Sha Tin Wai 2
Southwark 2
Surakarta 2
Torino 2
Vilnius 2
Vitulazio 2
Totale 2.008
Nome #
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab 126
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 118
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 118
Influence of age and subtype in outcome of operable liposarcoma 116
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 115
External accelerated partial breast irradiation for ductal carcinoma in situ: long-term follow-up from a phase 3 randomized trial 106
Radiotherapy in the age of cancer immunology: Current concepts and future developments 96
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 95
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 91
Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma 91
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 90
Partial breast irradiation for ductal carcinoma in situ: The Goldilocks principle? 83
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 83
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer 74
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 69
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 67
The Potential Role of Intensity-modulated Proton Therapy in the Regional Nodal Irradiation of Breast Cancer: A Treatment Planning Study 67
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 65
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 65
The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation 63
Pros-IT CNR: an Italian prostate cancer monitoring project 58
null 57
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review 42
Association of Breast Cancer Irradiation with Cardiac Toxic Effects: A Narrative Review 41
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 37
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 37
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 35
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 35
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 35
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 33
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 31
Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma 30
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 30
Acupuncture for radiation-induced toxicity in head and neck squamous cell carcinoma: a systematic review based on PICO criteria 30
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 28
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 26
Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review 25
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 24
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial 24
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 21
Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings 19
The impact of patient preference in the treatment algorithm for recurrent/metastatic head and neck squamous cell carcinoma 19
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 19
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 19
Radiomics in the setting of neoadjuvant radiotherapy: A new approach for tailored treatment 17
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 14
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 13
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 12
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 11
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 11
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 10
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 10
Radiobiology of stereotactic radiotherapy 10
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 10
Radiation therapy on the axilla after neoadjuvant chemotherapy 9
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 7
Totale 2.687
Categoria #
all - tutte 12.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020628 18 16 6 51 107 96 93 71 78 50 35 7
2020/2021226 27 13 15 34 10 7 9 20 23 27 21 20
2021/2022183 6 8 6 12 5 11 2 23 12 7 27 64
2022/2023867 52 153 49 24 67 153 103 92 120 4 27 23
2023/2024606 28 46 61 36 45 83 43 141 22 28 52 21
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 2.687